V024-5259 Screening compound: 3-(3-chlorophenyl)-1-({1-cyclohexyl-2-[(3-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-1-[2-(morpholin-4-yl)ethyl]urea

V024-5259 Screening compound: 3-(3-chlorophenyl)-1-({1-cyclohexyl-2-[(3-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-1-[2-(morpholin-4-yl)ethyl]urea
V024-5259 Screening compound: 3-(3-chlorophenyl)-1-({1-cyclohexyl-2-[(3-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-1-[2-(morpholin-4-yl)ethyl]urea alternative view

Chemical Structure Depiction of ChemDiv screening compound V024-5259
3-(3-chlorophenyl)-1-({1-cyclohexyl-2-[(3-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-1-[2-(morpholin-4-yl)ethyl]urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V024-5259

Molecular Formula

C31H40ClN5O4S (C31 H40 ClN5 O4 S)

Compound Name

3-(3-chlorophenyl)-1-({1-cyclohexyl-2-[(3-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-1-[2-(morpholin-4-yl)ethyl]urea

IUPAC name

3-(3-chlorophenyl)-1-({1-cyclohexyl-2-[(3-methylphenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-1-[2-(morpholin-4-yl)ethyl]urea

SMILES

Cc1cccc(CS(c2ncc(CN(CCN3CCOCC3)C(Nc3cccc(Cl)c3)=O)n2C2CCCCC2)(=O)=O)c1

InChI

InChI=1S/C31H40ClN5O4S/c1-24-7-5-8-25(19-24)23-42(39,40)31-33-21-29(37(31)28-11-3-2-4-12-28)22-36(14-13-35-15-17-41-18-16-35)30(38)34-27-10-6-9-26(32)20-27/h5-10,19-21,28H,2-4,11-18,22-23H2,1H3,(H,34,38)

InChI Key

NBOVTBWFWFMXBE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19820020

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

614.21

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

5.434

Distribution Coefficient, logD

5.009

Water Solubility, LogSw

-5.72

Polar Surface Area

77.858

Acid Dissociation Constant (pKa)

12.35

Base Dissociation Constant (pKb)

7.62

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

48.40

V024-5259 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Lipid Metabolism Library (9174 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cardiovascular
  • Metabolic
  • Nervous system
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with V024-5259 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V024-5259?
Check Price and Availability of V024-5259, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V024-5259 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V024-5259
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V024-5259
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V024-5259 available by request